235 related articles for article (PubMed ID: 22080998)
1. Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment.
Bryant MS; Rintala DH; Hou JG; Charness AL; Fernandez AL; Collins RL; Baker J; Lai EC; Protas EJ
Neurol Res; 2011 Nov; 33(9):959-64. PubMed ID: 22080998
[TBL] [Abstract][Full Text] [Related]
2. Gait variability in Parkinson's disease: levodopa and walking direction.
Bryant MS; Rintala DH; Hou JG; Collins RL; Protas EJ
Acta Neurol Scand; 2016 Jul; 134(1):83-6. PubMed ID: 26399376
[TBL] [Abstract][Full Text] [Related]
3. Locomotor response to levodopa in fluctuating Parkinson's disease.
Moore ST; MacDougall HG; Gracies JM; Ondo WG
Exp Brain Res; 2008 Feb; 184(4):469-78. PubMed ID: 17828529
[TBL] [Abstract][Full Text] [Related]
4. Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease.
Bryant MS; Rintala DH; Hou JG; Lai EC; Protas EJ
NeuroRehabilitation; 2011; 29(3):247-52. PubMed ID: 22142758
[TBL] [Abstract][Full Text] [Related]
5. Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues.
Rochester L; Baker K; Nieuwboer A; Burn D
Mov Disord; 2011 Feb; 26(3):430-5. PubMed ID: 21462258
[TBL] [Abstract][Full Text] [Related]
6. Gait stride-to-stride variability and foot clearance pattern analysis in Idiopathic Parkinson's Disease and Vascular Parkinsonism.
Ferreira F; Gago MF; Bicho E; Carvalho C; Mollaei N; Rodrigues L; Sousa N; Rodrigues PP; Ferreira C; Gama J
J Biomech; 2019 Jul; 92():98-104. PubMed ID: 31182234
[TBL] [Abstract][Full Text] [Related]
7. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa.
Schaafsma JD; Giladi N; Balash Y; Bartels AL; Gurevich T; Hausdorff JM
J Neurol Sci; 2003 Aug; 212(1-2):47-53. PubMed ID: 12809998
[TBL] [Abstract][Full Text] [Related]
8. Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
Kwon KY; Lee HM; Kang SH; Pyo SJ; Kim HJ; Koh SB
Gait Posture; 2017 Oct; 58():1-6. PubMed ID: 28692855
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopaminergic therapy on locomotor adaptation and adaptive learning in persons with Parkinson's disease.
Roemmich RT; Hack N; Akbar U; Hass CJ
Behav Brain Res; 2014 Jul; 268():31-9. PubMed ID: 24698798
[TBL] [Abstract][Full Text] [Related]
10. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
[TBL] [Abstract][Full Text] [Related]
11. Bilateral coordination of walking and freezing of gait in Parkinson's disease.
Plotnik M; Giladi N; Hausdorff JM
Eur J Neurosci; 2008 Apr; 27(8):1999-2006. PubMed ID: 18412621
[TBL] [Abstract][Full Text] [Related]
12. Reliability of the non-instrumented walk test in persons with Parkinson's disease.
Bryant MS; Rintala DH; Hou JG; Protas EJ
Disabil Rehabil; 2013 Apr; 35(7):538-42. PubMed ID: 22889283
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities in the stride length-cadence relation in parkinsonian gait.
Morris M; Iansek R; Matyas T; Summers J
Mov Disord; 1998 Jan; 13(1):61-9. PubMed ID: 9452328
[TBL] [Abstract][Full Text] [Related]
14. Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait.
Hausdorff JM; Schaafsma JD; Balash Y; Bartels AL; Gurevich T; Giladi N
Exp Brain Res; 2003 Mar; 149(2):187-94. PubMed ID: 12610686
[TBL] [Abstract][Full Text] [Related]
15. Variability in spatiotemporal gait characteristics over the course of the L-dopa cycle in people with advanced Parkinson disease .
MacKay-Lyons M
Phys Ther; 1998 Oct; 78(10):1083-94. PubMed ID: 9781702
[TBL] [Abstract][Full Text] [Related]
16. Gait analysis in advanced Parkinson's disease--effect of levodopa and tolcapone.
Shan DE; Lee SJ; Chao LY; Yeh SI
Can J Neurol Sci; 2001 Feb; 28(1):70-5. PubMed ID: 11252300
[TBL] [Abstract][Full Text] [Related]
17. Gait Characteristics under Imposed Challenge Speed Conditions in Patients with Parkinson's Disease During Overground Walking.
Lee M; Youm C; Noh B; Park H; Cheon SM
Sensors (Basel); 2020 Apr; 20(7):. PubMed ID: 32290054
[TBL] [Abstract][Full Text] [Related]
18. Prefrontal Cortex Activity and Gait in Parkinson's Disease With Cholinergic and Dopaminergic Therapy.
Stuart S; Morris R; Giritharan A; Quinn J; Nutt JG; Mancini M
Mov Disord; 2020 Nov; 35(11):2019-2027. PubMed ID: 32830901
[TBL] [Abstract][Full Text] [Related]
19. Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease.
Bastian AJ; Kelly VE; Perlmutter JS; Mink JW
Mov Disord; 2003 Sep; 18(9):1008-17. PubMed ID: 14502668
[TBL] [Abstract][Full Text] [Related]
20. Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesia.
Bowes SG; Clark PK; Charlett A; O'Neill CJ; Leeman AL; Weller C; Nicholson PW; Deshmukh AA; Dobbs SM; Dobbs RJ
Br J Clin Pharmacol; 1991 Mar; 31(3):295-304. PubMed ID: 2054270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
